2019
DOI: 10.1002/cbic.201900349
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Phosphodiester‐Linked 4‐Amino‐4‐deoxy‐l‐arabinose Derivatives Demonstrate that ArnT is an Inverting Aminoarabinosyl Transferase

Abstract: Abstract4‐Amino‐4‐deoxy‐l‐arabinopyranose (Ara4N) residues have been linked to antibiotic resistance due to reduction of the negative charge in the lipid A and core regions of the bacterial lipopolysaccharide (LPS). To study the enzymatic transfer of Ara4N onto lipid A, which is catalysed by the ArnT transferase, we chemically synthesised a series of anomeric phosphodiester‐linked lipid Ara4N derivatives containing linear aliphatic chains as well as E‐ and Z‐configured monoterpene units. Coupling reactions wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 52 publications
0
5
0
Order By: Relevance
“…On the other hand, we also note that the availability of BP glycose substrates is limited and that reverse reactions demonstrated here may be used to generate these substrates in vitro . As noted by Olagnon et al ., new strategies for acquiring and evaluating polyisoprenyl-phosphate intermediates will address the lack of available substrates required for the rational design of inhibitors, as well as limitations associated with clarifying the function of enzymes involved in lipid A modifications with cationic glycoses …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…On the other hand, we also note that the availability of BP glycose substrates is limited and that reverse reactions demonstrated here may be used to generate these substrates in vitro . As noted by Olagnon et al ., new strategies for acquiring and evaluating polyisoprenyl-phosphate intermediates will address the lack of available substrates required for the rational design of inhibitors, as well as limitations associated with clarifying the function of enzymes involved in lipid A modifications with cationic glycoses …”
Section: Discussionmentioning
confidence: 99%
“…As noted by Olagnon et al, new strategies for acquiring and evaluating polyisoprenyl-phosphate intermediates will address the lack of available substrates required for the rational design of inhibitors, as well as limitations associated with clarifying the function of enzymes involved in lipid A modifications with cationic glycoses. 42 Accordingly, this research directly addresses the deficit of polyisoprenoid substrates by demonstrating the utility of two efficient methods used to obtain both native and tagged BPglycoses. Specifically, we demonstrate the unique advantage of 2CN-BP used to selectively probe the activity of endogenous BP utilizing proteins within membrane fractions of both K-and Bstrains of E. coli.…”
Section: ■ Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have recently set out to study the substrate specificity of ArnT enzymes in more detail using phosphodiester-linked derivatives in both anomeric configurations and containing short lipid appendages in order to define the minimum structural requirements for Ara4N glycosyltransferase substrates [9]. In parallel, we have started to develop C-phosphonate analogues as these have frequently been exploited as potential inhibitors for glycosyl transferases since the carbon-phosphorus bond is not hydrolyzed in the active site of glycosyl transferases [10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…4-Amino-4-deoxy-L-arabinose units are activated as the phosphodiester linked undecaprenyl derivative [6] that is then transferred by the action of several Ara4N-transferases (ArnT) [7]. Synthesis of potential inhibitors of the biosynthesis of We have recently set out to study the substrate specificity of ArnT enzymes in more detail using phosphodiester linked derivatives in both anomeric configurations and containing short lipid appendages in order to define the minimum structural requirements for Ara4N glycosyltransferase substrates [9]. In parallel, we have started to develop C-phosphonate analogues as these have frequently been exploited as potential inhibitors for glycosyl transferases, since the carbonphosphorus bond is not hydrolyzed in the active site of glycosyl transferases [10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%